Long-term outcome by risk factors using conformal high-dose-rate brachytherapy (HDR-BT) boost with or without neoadjuvant androgen suppression for localized prostate cancer

Authors:
  • AMAlvaro Martinez
    Alvaro Martinez
  • TMTim Mate
    Tim Mate
  • CMChristina Mitchell
    Christina Mitchell
  • GEGregory Edmundson
    Gregory Edmundson
  • NNNils Nuernberg
    Nils Nuernberg
  • SEStephen Eulau
    Stephen Eulau
  • GGGary Gustafson
    Gary Gustafson
  • MGMichael Gribble
    Michael Gribble
  • GKGyoergy Kovács
    Gyoergy Kovács

Abstract
No abstract available

This publication has 25 references indexed in Scilit: